Aurion Biotech
Combination Product: AURN001 + Y-27632
Corneal Edema
Countdown
358days
Phase 3 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 3 trial results for Combination Product: AURN001 + Y-27632 in Corneal Edema are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT07368959: Phase 3 trial, sponsor Aurion Biotech, drug Combination Product: AURN001 + Y-27632. Primary completion date 2027-06 (estimated).”